Details of the Drug

General Information of Drug (ID: DMGWNCJ)

Drug Name
Ifabotuzumab
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 2 [1]
Myelodysplastic syndrome 2A37 Phase 2 [1]
Recurrent glioblastoma 2A00.00 Phase 1 [2]
Cross-matching ID
TTD ID
D08NZG
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ephrin type-A receptor 3 (EPHA3) TTHS2LR EPHA3_HUMAN Antagonist [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)